AR125423A1 - VACCINES AGAINST URINARY TRACT INFECTIONS - Google Patents

VACCINES AGAINST URINARY TRACT INFECTIONS

Info

Publication number
AR125423A1
AR125423A1 ARP190100614A ARP190100614A AR125423A1 AR 125423 A1 AR125423 A1 AR 125423A1 AR P190100614 A ARP190100614 A AR P190100614A AR P190100614 A ARP190100614 A AR P190100614A AR 125423 A1 AR125423 A1 AR 125423A1
Authority
AR
Argentina
Prior art keywords
urinary tract
tract infections
vaccines against
against urinary
coli
Prior art date
Application number
ARP190100614A
Other languages
Spanish (es)
Inventor
Jan Theunis Poolman
Jeroen Geurtssen
Kellen Cristhina Fae
Original Assignee
Janssen Vaccines & Prevention Bv
Janssen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Vaccines & Prevention Bv, Janssen Pharmaceuticals Inc filed Critical Janssen Vaccines & Prevention Bv
Publication of AR125423A1 publication Critical patent/AR125423A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Composiciones y métodos para vacunar contra infecciones del tracto urinario provocadas por E. coli. Las composiciones comprenden un polipéptido FimH, uno o más conjugados que comprenden antígenos O de polisacáridos de E. coli unidos en forma covalente a una proteína transportadora y un adyuvante.Compositions and methods for vaccinating against urinary tract infections caused by E. coli. The compositions comprise a FimH polypeptide, one or more conjugates comprising E. coli polysaccharide O antigens covalently linked to a carrier protein, and an adjuvant.

ARP190100614A 2018-08-23 2019-03-12 VACCINES AGAINST URINARY TRACT INFECTIONS AR125423A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201818190402A 2018-08-23 2018-08-23
US202018161252A 2020-03-12 2020-03-12

Publications (1)

Publication Number Publication Date
AR125423A1 true AR125423A1 (en) 2023-07-19

Family

ID=87551301

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190100614A AR125423A1 (en) 2018-08-23 2019-03-12 VACCINES AGAINST URINARY TRACT INFECTIONS

Country Status (1)

Country Link
AR (1) AR125423A1 (en)

Similar Documents

Publication Publication Date Title
CY1124488T1 (en) PROTEIN RELEASE BASED ON INFECTIOUSNESS-ATTAINED BACTERIA
BR112018070919A2 (en) anti-tim-3 antibodies and compositions
MX2022014125A (en) Antibodies and conjugates thereof.
MX2018002340A (en) Methods and compositions for immune protection against extra-intestinal pathogenic e. coli.
AR105470A1 (en) METHODS TO INDUCE AN IMMUNE RESPONSE
CR20170139A (en) FUSION PROTEINS, RECOMBINANT BACTERIA AND METHODS OF USE OF THE RECOMBINANT BACTERIA
BR112017001588A2 (en) cdh6 antibody / drug conjugates
CL2015001902A1 (en) Vaccines with higher density of antigen carbohydrate and new adjuvant of saponin (divisional).
EA201000903A1 (en) ANTITEL TO PCRV-ANTIGEN PSEUDOMONAS AERUGINOSA
CO2019003949A2 (en) Expec glycoconjugate vaccine formulations
MX2020004543A (en) Zika vaccines and immunogenic compositions, and methods of using the same.
BR112017011478A2 (en) antibody-antibiotic conjugate compound, antibody-antibiotic conjugate, pharmaceutical composition, methods of treating a bacterial infection and exterminating staph aureus, process for compound preparation, kit and antibiotic-binder intermediate
CL2019002716A1 (en) Methods and compositions for the reduction of immunogenicity
EA202091690A1 (en) IMMUNOGENIC COMPOSITION CONTAINING STAPHYLOCOCCAL ANTIGENS
GEP201706766B (en) Methods and compositions for vaccinating against staphylococcus aureus
CO2021001926A2 (en) Escherichia coli compositions and methods
EA202190653A1 (en) CONJUGATES OF BINDING PROTEIN WITH TOXIN CONTAINING ANTHRACYCLINES AND THEIR USE FOR IMMUNO-ONCOLOGICAL PURPOSES
AR096123A1 (en) COMPOSITIONS AND PROCEDURES TO INDUCE IMMUNE TOLERANCE TO COAGULATION FACTORY PROTEINS
EA201990451A1 (en) COMPOSITION OF MULTI-VALENT PNEUMO-COCK CAPSULE POLYSACCHARIDE COMPOUNDS WITH PROTEIN-CARRIER AND ITS APPLICATION
AR100365A1 (en) WATERPROOF COMPOSITION INCLUDING IBUPROFEN AND PARACETAMOL IN COMBINATION, PROCESS TO MANUFACTURE AND INJECTOR DEVICE FOR ADMINISTRATE
BR112016015078A2 (en) method for preventing or treating h7n9 influenza virus infection, antibody use and pharmaceutical composition
AR125423A1 (en) VACCINES AGAINST URINARY TRACT INFECTIONS
PE20190225A1 (en) A METHOD TO REDUCE EGG CONTAMINATION
AR114693A1 (en) VACCINES AGAINST INTRAABDOMINAL INFECTIONS
PL404229A1 (en) Isolated immunogenic bacterial antigen and its use in the prevention and treatment of infections caused by Gram-negative bacteria